颗粒细胞母细胞瘤:一个罕见的病例报告与公共卫生影响
Shyamkumar Sriram1, Shamimul Hasan2, Mambakkam Jayakanth3
1Department of Rehabilitation and Health Services, College of Health and Public Service, University of North Texas, Denton, TX.
Medicine
|May 12, 2025
概括
本案例研究详细介绍了一种罕见的颗粒细胞细胞母细胞瘤,强调激进手术对于管理这种侵略性牙瘤和预防复发至关重要.
科学领域:
- 口腔和牙面部外科手术
- 在瘤学瘤学.
- 病理学 病理学 病理学
背景情况:
- 骨髓母细胞瘤是局部具有侵略性的良性牙致癌瘤,复发率高.
- 组织病理多样性和并发症带来了诊断和治疗的挑战.
- 本案重点关注一种罕见的颗粒细胞细胞母细胞瘤变体.
研究的目的:
- 为了呈现一个颗粒细胞细胞母细胞瘤的病例.
- 为了说明其临床,放射和组织病理学特征.
- 强调激进的外科管理的重要性.
主要方法:
- 一个46岁的女性呈现了10个月的下下巴胀史.
- 临床检查显示了面部不对称性和硬下部胀.
- 放射性成像显示了一个多局部放射性光病变,具有特征性的"肥泡"和"牙漂浮在空气中"的外观.
- 切口活检和随后的组织病理学证实了颗粒细胞母细胞瘤.
主要成果:
- 患者接受了细分下切除术和瘤切除术.
- 手术后的康复是没有事件的.
- 在2年的随访期间,没有观察到复发或转移.
结论:
- 颗粒细胞细胞母细胞瘤需要与其他牙新生瘤区分开来.
- 准确的诊断依赖于综合的临床,放射和组织病理学评估.
- 激进的手术治疗对于管理局部侵袭性瘤和预防复发至关重要.
- 长期跟踪对于监测复发至关重要.
相关概念视频
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Cancer Stem Cells and Tumor Maintenance
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...


